Human Apolipoprotein A-I
Cat# MBS7041640-5x1mg
Size : 5x1mg
Brand : MyBiosource
Apolipoprotein A-I (APOA1) Human Antigen
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS7041640MBS7041640 is an antigen targeting APOA1. Also known as Human Apolipoprotein A-I. More details
Product Overview
Online Datasheet in PDFProduct Name
Apolipoprotein A-I (APOA1), Antigen
Full Product Name
Human Apolipoprotein A-I
Product Gene Name
APOA1 antigen
Form/Format
Liquid
Purity/Purification
>95% by SDS-PAGE
Preparation and Storage
Aliquot and store at -20 degree C or -80 degree C. Avoid repeated freeze / thaw cycles.
Molecular Weight
30,778 Da
OMIM
105200
Antibody Type
Recombinant
Product Note
Applications are user defined. Product is developed and quality control tested in house, data or additional information may be provided upon request. The researcher needs to establish and confirm the suitability of the product for their application.
Product Categories/Family for APOA1 antigen
Cardiovascular Disease; Raw Materials Assay Development
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Applications Tested/Suitable for APOA1 antigen
Calibrator, Western Blot (WB)
Other Notes
Small volumes of APOA1 antigen vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for APOA1. It may not necessarily be applicable to this product.
NCBI Official Full Name
apolipoprotein A-I isoform 2
NCBI Official Synonym Full Names
apolipoprotein A1
NCBI Official Symbol
APOA1
NCBI Official Synonym Symbols
apo(a)
UniProt Protein Name
Apolipoprotein A-I
UniProt Synonym Protein Names
Apolipoprotein A1
Protein Family
Apolipoprotein
UniProt Gene Name
APOA1
UniProt Synonym Gene Names
Apo-AI; ApoA-I; ProapoA-I
UniProt Entry Name
APOA1_HUMAN
NCBI Protein Information
apolipoprotein A-I
NCBI Summary for APOA1
This gene encodes apolipoprotein A-I, which is the major protein component of high density lipoprotein (HDL) in plasma. The encoded preproprotein is proteolytically processed to generate the mature protein, which promotes cholesterol efflux from tissues to the liver for excretion, and is a cofactor for lecithin cholesterolacyltransferase (LCAT), an enzyme responsible for the formation of most plasma cholesteryl esters. This gene is closely linked with two other apolipoprotein genes on chromosome 11. Defects in this gene are associated with HDL deficiencies, including Tangier disease, and with systemic non-neuropathic amyloidosis. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein. [provided by RefSeq, Dec 2015]
Show more UniProt Comments for APOA1
APOA1: Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase (LCAT). As part of the SPAP complex, activates spermatozoa motility. Interacts with APOA1BP and CLU. Component of a sperm activating protein complex (SPAP), consisting of APOA1, an immunoglobulin heavy chain, an immunoglobulin light chain and albumin. Interacts with NDRG1. Major protein of plasma HDL, also found in chylomicrons. Synthesized in the liver and small intestine. The oxidized form at Met-110 and Met-136 is increased in individuals with increased risk for coronary artery disease, such as in carrier of the eNOSa/b genotype and exposure to cigarette smoking. It is also present in increased levels in aortic lesions relative to native ApoA-I and increased levels are seen with increasing severity of disease. Belongs to the apolipoprotein A1/A4/E family.
Protein type: Endoplasmic reticulum; Secreted; Motility/polarity/chemotaxis; Lipid-binding; Secreted, signal peptide; Cell development/differentiation; Vesicle
Chromosomal Location of Human Ortholog: 11q23-q24
Cellular Component: cell surface; chylomicron; cytoplasmic vesicle; cytosol; early endosome; endocytic vesicle; endoplasmic reticulum lumen; extracellular region; extracellular space; nucleus; plasma membrane
Molecular Function: apolipoprotein A-I receptor binding; apolipoprotein receptor binding; beta-amyloid binding; chemorepellent activity; cholesterol binding; cholesterol transporter activity; enzyme binding; high-density lipoprotein binding; identical protein binding; lipase inhibitor activity; phosphatidylcholine binding; phospholipid binding; phospholipid transporter activity; protein binding
Biological Process: adrenal gland development; axon regeneration in the peripheral nervous system; blood vessel endothelial cell migration; cellular protein metabolic process; cholesterol biosynthetic process; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transport; endothelial cell proliferation; G-protein coupled receptor protein signaling pathway; glucocorticoid metabolic process; integrin-mediated signaling pathway; lipoprotein biosynthetic process; lipoprotein metabolic process; negative chemotaxis; negative regulation of cytokine secretion during immune response; negative regulation of heterotypic cell-cell adhesion; negative regulation of inflammatory response; negative regulation of interleukin-1 beta secretion; negative regulation of lipase activity; neurite regeneration; organ regeneration; peptidyl-methionine modification; phosphatidylcholine biosynthetic process; phospholipid efflux; phospholipid homeostasis; platelet degranulation; positive regulation of fatty acid biosynthetic process; positive regulation of hydrolase activity; positive regulation of lipoprotein lipase activity; positive regulation of Rho protein signal transduction; positive regulation of stress fiber formation; protein amino acid oxidation; protein stabilization; receptor-mediated endocytosis; regulation of Cdc42 protein signal transduction; regulation of cholesterol absorption; regulation of protein amino acid phosphorylation; response to drug; response to estrogen stimulus; response to nutrient; retinoid metabolic process; reverse cholesterol transport; sequestering of lipid; transforming growth factor beta receptor signaling pathway; transmembrane transport; triacylglycerol catabolic process; vitamin transport
Disease: Amyloidosis, Familial Visceral; Hypoalphalipoproteinemia, Primary
Show more Protein type: Endoplasmic reticulum; Secreted; Motility/polarity/chemotaxis; Lipid-binding; Secreted, signal peptide; Cell development/differentiation; Vesicle
Chromosomal Location of Human Ortholog: 11q23-q24
Cellular Component: cell surface; chylomicron; cytoplasmic vesicle; cytosol; early endosome; endocytic vesicle; endoplasmic reticulum lumen; extracellular region; extracellular space; nucleus; plasma membrane
Molecular Function: apolipoprotein A-I receptor binding; apolipoprotein receptor binding; beta-amyloid binding; chemorepellent activity; cholesterol binding; cholesterol transporter activity; enzyme binding; high-density lipoprotein binding; identical protein binding; lipase inhibitor activity; phosphatidylcholine binding; phospholipid binding; phospholipid transporter activity; protein binding
Biological Process: adrenal gland development; axon regeneration in the peripheral nervous system; blood vessel endothelial cell migration; cellular protein metabolic process; cholesterol biosynthetic process; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transport; endothelial cell proliferation; G-protein coupled receptor protein signaling pathway; glucocorticoid metabolic process; integrin-mediated signaling pathway; lipoprotein biosynthetic process; lipoprotein metabolic process; negative chemotaxis; negative regulation of cytokine secretion during immune response; negative regulation of heterotypic cell-cell adhesion; negative regulation of inflammatory response; negative regulation of interleukin-1 beta secretion; negative regulation of lipase activity; neurite regeneration; organ regeneration; peptidyl-methionine modification; phosphatidylcholine biosynthetic process; phospholipid efflux; phospholipid homeostasis; platelet degranulation; positive regulation of fatty acid biosynthetic process; positive regulation of hydrolase activity; positive regulation of lipoprotein lipase activity; positive regulation of Rho protein signal transduction; positive regulation of stress fiber formation; protein amino acid oxidation; protein stabilization; receptor-mediated endocytosis; regulation of Cdc42 protein signal transduction; regulation of cholesterol absorption; regulation of protein amino acid phosphorylation; response to drug; response to estrogen stimulus; response to nutrient; retinoid metabolic process; reverse cholesterol transport; sequestering of lipid; transforming growth factor beta receptor signaling pathway; transmembrane transport; triacylglycerol catabolic process; vitamin transport
Disease: Amyloidosis, Familial Visceral; Hypoalphalipoproteinemia, Primary
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with APOA1 antigen
| Reference Product | PubMed Publications |
|---|---|
| APOB antigen | >584 publications with APOA1 and APOB |
| APOE antigen | >173 publications with APOA1 and APOE |
| ABCA1 antigen | >170 publications with APOA1 and ABCA1 |
| APOC3 antigen | >82 publications with APOA1 and APOC3 |
| CETP antigen | >71 publications with APOA1 and CETP |
| LCAT antigen | >48 publications with APOA1 and LCAT |
| APOA2 antigen | >47 publications with APOA1 and APOA2 |
| TTR antigen | >11 publications with APOA1 and TTR |
| FGA antigen | >4 publications with APOA1 and FGA |
| HNF4A antigen | >4 publications with APOA1 and HNF4A |
Pathways associated with APOA1 antigen
| Products by Pathway | Pathway Diagram |
|---|---|
| ABC Transporters In Lipid Homeostasis Pathway antibodies | ABC Transporters In Lipid Homeostasis Pathway Diagram |
| ABC-family Proteins Mediated Transport Pathway antibodies | ABC-family Proteins Mediated Transport Pathway Diagram |
| African Trypanosomiasis Pathway antibodies | African Trypanosomiasis Pathway Diagram |
| African Trypanosomiasis Pathway antibodies | African Trypanosomiasis Pathway Diagram |
| Amyloid Fiber Formation Pathway antibodies | Amyloid Fiber Formation Pathway Diagram |
| Binding And Uptake Of Ligands By Scavenger Receptors Pathway antibodies | Binding And Uptake Of Ligands By Scavenger Receptors Pathway Diagram |
| Chylomicron-mediated Lipid Transport Pathway antibodies | Chylomicron-mediated Lipid Transport Pathway Diagram |
| FOXA2 And FOXA3 Transcription Factor Networks Pathway antibodies | FOXA2 And FOXA3 Transcription Factor Networks Pathway Diagram |
| Fat Digestion And Absorption Pathway antibodies | Fat Digestion And Absorption Pathway Diagram |
| Fat Digestion And Absorption Pathway antibodies | Fat Digestion And Absorption Pathway Diagram |
Diseases associated with APOA1 antigen
| Disease Name | Pubmed Publications |
|---|---|
| Cardiovascular Diseases Antibodies | >532 publications with APOA1 and Cardiovascular Diseases |
| Atherosclerosis Antibodies | >330 publications with APOA1 and Atherosclerosis |
| Dyslipidemias Antibodies | >213 publications with APOA1 and Dyslipidemias |
| Heart Diseases Antibodies | >200 publications with APOA1 and Heart Diseases |
| Inflammation Antibodies | >138 publications with APOA1 and Inflammation |
| Hyperlipidemias Antibodies | >134 publications with APOA1 and Hyperlipidemias |
| Coronary Artery Disease Antibodies | >119 publications with APOA1 and Coronary Artery Disease |
| Hypertension Antibodies | >92 publications with APOA1 and Hypertension |
| Hypercholesterolemia Antibodies | >74 publications with APOA1 and Hypercholesterolemia |
| Liver Diseases Antibodies | >65 publications with APOA1 and Liver Diseases |
Organs/Tissues associated with APOA1 antigen
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >931 publications with APOA1 and Blood |
| Liver Antibodies | >217 publications with APOA1 and Liver |
| Heart Antibodies | >186 publications with APOA1 and Heart |
| Brain Antibodies | >43 publications with APOA1 and Brain |
| Muscle Antibodies | >31 publications with APOA1 and Muscle |
| Lung Antibodies | >30 publications with APOA1 and Lung |
| Intestine Antibodies | >21 publications with APOA1 and Intestine |
| Ovary Antibodies | >17 publications with APOA1 and Ovary |
| Pancreas Antibodies | >9 publications with APOA1 and Pancreas |
| Embryonic Tissue Antibodies | >4 publications with APOA1 and Embryonic Tissue |


